Ninety One North America’s Elevance Health ELV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$2M Hold
5,170
0.09% 90
2026
Q1
$1.51M Buy
5,170
+33
+0.6% +$10.8K 0.07% 87
2025
Q4
$1.8M Buy
+5,137
New +$1.74M 0.07% 88
2022
Q2
Sell
-7,845
Closed -$3.85M 86
2022
Q1
$3.85M Buy
7,845
+1,552
+25% +$709K 0.14% 80
2021
Q4
$2.92M Sell
6,293
-251
-4% -$106K 0.1% 93
2021
Q3
$2.44M Buy
6,544
+125
+2% +$47.5K 0.11% 90
2021
Q2
$2.45M Sell
6,419
-117
-2% -$44.7K 0.11% 94
2021
Q1
$2.35M Sell
6,536
-193
-3% -$62.1K 0.14% 98
2020
Q4
$2.16M Sell
6,729
-51
-0.8% -$15.7K 0.13% 96
2020
Q3
$1.82M Sell
6,780
-108
-2% -$29.1K 0.2% 90
2020
Q2
$1.81M Hold
6,888
0.19% 85
2020
Q1
$1.56M Sell
6,888
-70,815
-91% -$19.3M 0.13% 74
2019
Q4
$23.5M Sell
77,703
-4,062
-5% -$1.12M 1.91% 21
2019
Q3
$19.6M Buy
81,765
+4,697
+6% +$1.29M 1.77% 27
2019
Q2
$21.7M Buy
77,068
+5,541
+8% +$1.51M 1.91% 25
2019
Q1
$20.5M Sell
71,527
-54
-0.1% -$15.6K 1.94% 19
2018
Q4
$18.8M Buy
+71,581
New +$19.7M 2% 18

Other funds holding ELV

Ninety One North America's ELV Position: Q2 2026 in Review

Ninety One North America held its Elevance Health (ELV) position steady in Q2 2026 at 5,170 shares worth $2M. The position accounts for 0.09% of the portfolio, ranked #90.

Ninety One North America first reported a position in ELV in Q4 2018 and has held it in 17 quarters since. The position peaked at $23.5M in Q4 2019. 617 funds tracked by Wall St. Rank hold ELV as of Q2 2026.

  • Ninety One North America held 5,170 shares of Elevance Health worth $2M as of Q2 2026.
  • Ninety One North America left its Elevance Health share count unchanged in Q2 2026.
  • Elevance Health made up 0.09% of Ninety One North America's portfolio in Q2 2026, its #90 holding.
  • Ninety One North America first reported a position in Elevance Health in Q4 2018 and has held it in 17 quarters since.
  • Ninety One North America's Elevance Health position peaked at $23.5M in Q4 2019.
  • 617 funds tracked by Wall St. Rank held Elevance Health as of Q2 2026.

Based on Ninety One North America's 13F filing for Q2 2026, filed 16 Jul 2026.